Credit Suisse’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-52,364
| Closed | -$7.92M | – | 4247 |
|
|
2022
Q3 | $7.92M | Sell |
52,364
-1,059
| -2% | -$160K | 0.01% | 1007 |
|
|
2022
Q2 | $7.79M | Sell |
53,423
-2,066
| -4% | -$301K | 0.01% | 1024 |
|
|
2022
Q1 | $6.58M | Buy |
55,489
+5,040
| +10% | +$598K | 0.01% | 1268 |
|
|
2021
Q4 | $6.95M | Buy |
50,449
+3,562
| +8% | +$491K | ﹤0.01% | 1305 |
|
|
2021
Q3 | $6.51M | Buy |
46,887
+6,534
| +16% | +$908K | ﹤0.01% | 1361 |
|
|
2021
Q2 | $3.95M | Buy |
40,353
+2,161
| +6% | +$211K | ﹤0.01% | 1697 |
|
|
2021
Q1 | $2.61M | Sell |
38,192
-36,286
| -49% | -$2.48M | ﹤0.01% | 1980 |
|
|
2020
Q4 | $6.38M | Buy |
74,478
+5,164
| +7% | +$443K | ﹤0.01% | 1371 |
|
|
2020
Q3 | $4.51M | Sell |
69,314
-11,079
| -14% | -$720K | ﹤0.01% | 1343 |
|
|
2020
Q2 | $5.88M | Buy |
80,393
+4,992
| +7% | +$365K | ﹤0.01% | 1224 |
|
|
2020
Q1 | $2.57M | Sell |
75,401
-6,527
| -8% | -$222K | ﹤0.01% | 1521 |
|
|
2019
Q4 | $4.46M | Buy |
81,928
+45,377
| +124% | +$2.47M | ﹤0.01% | 1484 |
|
|
2019
Q3 | $1.53M | Sell |
36,551
-83,291
| -70% | -$3.48M | ﹤0.01% | 2127 |
|
|
2019
Q2 | $5.25M | Buy |
119,842
+97,437
| +435% | +$4.27M | ﹤0.01% | 1313 |
|
|
2019
Q1 | $1.15M | Buy |
22,405
+1,092
| +5% | +$56.2K | ﹤0.01% | 2263 |
|
|
2018
Q4 | $788K | Sell |
21,313
-24,145
| -53% | -$893K | ﹤0.01% | 2472 |
|
|
2018
Q3 | $1.71M | Buy |
45,458
+20,239
| +80% | +$760K | ﹤0.01% | 2053 |
|
|
2018
Q2 | $997K | Buy |
25,219
+250
| +1% | +$9.88K | ﹤0.01% | 2582 |
|
|
2018
Q1 | $643K | Buy |
24,969
+14,800
| +146% | +$381K | ﹤0.01% | 2821 |
|
|
2017
Q4 | $274K | Buy |
10,169
+2,610
| +35% | +$70.3K | ﹤0.01% | 3161 |
|
|
2017
Q3 | $282K | Buy |
+7,559
| New | +$282K | ﹤0.01% | 3288 |
|